Navigation Links
Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
Date:9/21/2009

SAN FRANCISCO, Sept. 21 /PRNewswire/ -- The TCT 2009 meeting will feature an unusual amount of novel information about Vulnerable Coronary Artery Plaque, the structure widely considered to be the primary cause of acute coronary events, the leading cause of death in the developed world. The concept of Vulnerable Plaque has been a topic of study for over 2 decades. TCT will showcase progress on a number of diagnostic catheters designed to identify the lipid core plaques that are widely suspected to be vulnerable.

  • Monday, September 21 -- Four presentations in the day-long Vulnerable Plaque Symposium describing the experience with LipiScan, a novel near-infrared spectroscopy catheter (InfraReDx, Inc.) approved in 2008 by the FDA for identification of lipid core plaques. (Room 131)
  • Thursday, September 24 -- Dr. Gregg Stone will present the results of the 3 year follow-up of suspected vulnerable plaques in the Prospect Trial, a study of over 700 patients with multi-vessel ultrasound (Virtual Histology, Volcano, Inc.) measurements at baseline. This major trial is the first, large, long-term study of the hypothesis that harmful vulnerable plaques can be identified before they cause a coronary event. (Room 300)

In 1989, Dr. James Muller and colleagues introduced the term "Vulnerable Plaque" to describe a plaque at high risk of disruption that leads to coronary thrombosis. Dr. Muller, CEO of InfraReDx, Inc. participated in the company's founding in 1998 for the purpose of developing a spectroscopic catheter to detect vulnerable plaque. Dr. Muller will be available at TCT to comment on the important developments related to vulnerable plaque reported at the meeting, including commentary on the outcome of the Prospect Trial. Dr. Muller and his colleague, Jim Dillon, Vice-President of Sales and Marketing at InfraReDx, Inc. will be available for comment on the use
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Web Site Will Help Pennsylvanians Learn About, Protect Against Novel H1N1 Flu
2. The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018
3. Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
4. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
5. Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic
6. Solution to PREVENT Novel H1N1 (Swine Flu) From Closing Down Schools!
7. The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium
8. Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
9. Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates
10. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
11. Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 & Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... WA (PRWEB) September 17, 2014 A ... in fiscal year 2010 revealed 3.2% of these patients developed ... and 2.4% labeled as superficial SSIs. The average difference for ... 876, after adjustments. , The study, conducted by Marin Schweizer, ... the University of Iowa, found the treatment costs for the ...
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 Representatives with ... an official sponsor of Thursday’s Anti-Defamation League Event at the ... this and we consider it an honor to be a ... of Capitol Pain Institute. , Schocket went on to explain ... more than 600 community leaders and members at the Four ...
(Date:9/17/2014)... 17, 2014 The probability of prostate ... regular screening and examination, a healthy diet could decrease ... Epicure with the Chef MDs, renowned Chef ... Rusilko to prepare a delicious Fish Moilee. , Dr. ... that influence risk of prostate cancer, uncommonly found in ...
(Date:9/17/2014)... 2014 Neon Sport and Fitmark have ... fitness industry’s most anticipated event, Joe Weider's Olympia Fitness ... will each take home a Neon Sport branded Fitmark ... and gear. Fitmark will hold entries for the special ... 19-20th. , “There’s nothing more exciting than seeing ...
(Date:9/17/2014)... Zagreb, Croatia (PRWEB) September 17, 2014 ... has released the new major version 6.0 of ... created for Windows Server monitoring and reporting. It ... new server reports, real-time e-mail alerts, and enhanced ... critical servers. , Server Monitoring Toolkit provides agentless ...
Breaking Medicine News(10 mins):Health News:Three Ways to Minimize Costs Associated with Surgical Site Infections 2Health News:Capitol Pain Institute Sponsoring an Anti-Defamation League Event & Awards Dinner 2Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3
... a protein that helps control inflammation may be a ... diabetes, researchers say. Georgia Health Sciences University researchers are ... IL-1ra, in children being closely followed because their genes ... also are looking at diabetic mice missing IL-1ra to ...
... (HealthDay News) -- While it may be true that beauty ... model helps reveal what,s behind peoples, ideas of facial attractiveness. ... "average" faces and those who fit the conventional notion of ... "femininity" in women. But psychologists Christopher P. Said of New ...
... 22 (HealthDay News) -- Patients hospitalized for treatment of ... of death if they become infected with Clostridium ... includes Crohn,s disease and ulcerative colitis. When people with ... the researchers at Imperial College London and St. George,s ...
... FRIDAY, April 22 (HealthDay News) -- Most children born ... different prognosis from the near-certain death that awaited HIV-infected ... tracking children with HIV, the AIDS-causing virus, to better ... "About two thirds of these kids, at this ...
... , FRIDAY, April 22 (HealthDay News) -- Women ... likely to have children with behavioral problems, a new ... the Telethon Institute for Child Health Research in Perth, ... research had shown a link between stress during pregnancy ...
... HealthDay Reporter , THURSDAY, April 21 (HealthDay News) ... higher risk of serious blood clots than earlier oral contraceptives. ... new type of progestogen hormone, had double to triple the ... according to two studies published online April 22 in ...
Cached Medicine News:Health News:Protein levels could signal that a child will develop diabetes 2Health News:What Makes a Face Appealing to the Opposite Sex? 2Health News:Hospital Infection Raises Death Risk for Bowel Patients 2Health News:HIV Kids Growing Up Well, Study Finds 2Health News:Pregnant and Stressed May Mean Offspring Who Misbehave 2Health News:Newer 'Pill' Linked to Higher Risk of Blood Clots 2Health News:Newer 'Pill' Linked to Higher Risk of Blood Clots 3
(Date:9/17/2014)... Pa. , Sept. 17, 2014  Fortune Oil ... officially changed its name to Manzo Pharmaceuticals, Inc. with ... to take effect today, September 17, 2014. Also taking ... The approval is a pivotal event in ... . Mr. Manzo explained, "We could not proceed with ...
(Date:9/17/2014)...  Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), ... received an unsolicited, non-binding proposal from Endo International plc ... the outstanding shares of Auxilium common stock at a ... stock, subject to due diligence, financing and other conditions. ... received from Endo on Friday evening is reproduced below. ...
(Date:9/17/2014)... 2014 Mindray (NYSE: MR)announced its new generation ... system has been showcased for the first time at ... September, and is scheduled for availability in the U.S. ... the most efficient workhorse in the mid-range segment, the ... perfectly optimized user experience including a gesture-sensitive touch screen, ...
Breaking Medicine Technology:Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 2Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 3Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Quality Exams at Your Fingertips 2
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: